Idiopathic inflammatory myopathy
MONDO:0600023Idiopathic form of inflammatory myopathy.
Also known as: idiopathic myositis
182 clinical trials for this condition and its sub-types, 60 tagged with Idiopathic inflammatory myopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Idiopathic inflammatory myopathy
-
Acquired idiopathic inflammatory myopathy 67 trials · 159 incl. sub-types
9 sub-types
- Polymyositis 36 trials · 100 incl. sub-types Sub-types →
- Juvenile idiopathic inflammatory myopathy 2 trials · 42 incl. sub-types Sub-types →
- Antisynthetase syndrome 21 trials
- Immune-mediated necrotizing myopathy 17 trials
- Overlap myositis 2 trials
- Eosinophilic fasciitis 1 trial
- Focal myositis 0 trials
- Idiopathic eosinophilic myositis 0 trials
- Inflammatory myopathy with abundant macrophages 0 trials
Most studied deeper sub-types
-
Experimental cell therapy takes on stubborn autoimmune diseases
Disease control Stopped earlyThis early study tested a new cell therapy called LUCAR-G79 in just 3 adults with severe autoimmune diseases that did not respond to standard treatments. The therapy uses specially engineered immune cells to target and potentially calm the overactive immune system. The main goals…
Phase 1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental CAR t therapy targets lupus and related diseases – but trial ends early
Disease control Stopped earlyThis early-phase trial tested a single infusion of IMPT-514, a personalized CAR T cell therapy, in 3 adults with severe lupus, vasculitis, or inflammatory myopathy that did not respond to standard treatments. The goal was to check safety and see if the therapy could reset the imm…
Early phase 1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New PET tracer aims to light up inflammation in joint and muscle diseases
Diagnosis Stopped earlyThis early-phase study tested a new radioactive imaging drug called 11C-MC1 to see if it can help detect inflammation in people with rheumatoid arthritis or idiopathic inflammatory myopathy, as well as in healthy volunteers. Participants received PET/CT scans after an injection o…
Phase 1 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Diagnosis
Last updated Jun 26, 2026 18:25 UTC